SQUAWK/NEWS
Menu
Live News EQUITY L impact

UroGen Pharma Files SEC Form

UroGen Pharma submits regulatory filing with the SEC. The filing is available for public review.

URGN

Filed: 2026-05-27 AccNo: 0001437749-26-018442 Size: 6 KB